Can K-ras codon 12 mutations be used to distinguish benign bile duct proliferations from metastases in the liver? A molecular analysis of 101 liver lesions from 93 patients.
Ralph H. Hruban(Johns Hopkins University), G. J. A. Offerhaus, Charles J. Yeo(Thomas Jefferson University), Patrick Sturm(Laurentius Ziekenhuis), Marie‐Louise F. van Velthuysen(Erasmus MC), T. A. Sohn, Robb E. Wilentz(Johns Hopkins University), Alex R. Musler(Amsterdam UMC Location University of Amsterdam), Robbert J.C. Slebos(University of Iowa)
PubMed
October 1, 1997
Cited by 34
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
|Cancer Cell|2017|2.1k